title: Rapamycin inhibits osteoclast formation in giant cell tumor of bone through the C/EBPβ - MafB axis.
abstract: Giant cell tumor (GCT) of bone is a benign type of tumor, but the presence of hyperactive multinucleated giant osteoclasts cause local osteolytic lesions, increasing morbidity in patients. To specifically target hyperactive multinucleated giant osteoclasts in GCTs, one would envisage the usage of osteoclast inhibitors or genetic modulation of osteoclastogenesis. Recently, we have found that the translationally regulated balance between the transcription factor C/EBPβ long (LAP) and short (LIP) protein isoforms regulates osteoclast differentiation. Here, we report that GCTs express high levels of the LIP C/EBPβ isoform, which in mice cause giant osteoclast formation. In mice, inhibition of mTOR activity by rapamycin decreased osteoclast differentiation by shifting the alternative translation initiation of C/EBPβ isoforms towards LAP. Similarly, rapamycin treatment of GCT cell cultures derived from seven different patients strongly reduced formation of giant osteoclasts and bone resorption. This was accompanied by an increase in MafB, previously shown to be the mediator of the effect of rapamycin on osteoclast differentiation in mice. These data suggest that C/EBPβ is a determinant of giant osteoclast formation in GCT and that pharmacological adjustment of the C/EBPβ isoform ratio could serve as a potential novel therapeutic approach.
authors.affiliation: Max Delbrueck Center for Molecular Medicine, Robert-Roessle-Str.10, 13125 Berlin, Germany.
authors.forename: Jeske J
authors.initials: JJ
authors.lastname: Smink
authors.forename: Per-Ulf
authors.initials: PU
authors.lastname: Tunn
authors.forename: Achim
authors.initials: A
authors.lastname: Leutz
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001859:Bone Neoplasms / Q000378:metabolism*; D001862:Bone Resorption / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism; D022782:CCAAT-Enhancer-Binding Protein-beta / Q000235:genetics / Q000378:metabolism*; D002478:Cells, Cultured; D018212:Giant Cell Tumor of Bone / Q000378:metabolism*; D006801:Humans; D051258:MafB Transcription Factor / Q000378:metabolism*; D010010:Osteoclasts / Q000187:drug effects* / Q000378:metabolism*; D021381:Protein Transport; D020123:Sirolimus / Q000494:pharmacology*
chemical_list: D000903:Antibiotics, Antineoplastic; D022782:CCAAT-Enhancer-Binding Protein-beta; D051258:MafB Transcription Factor; D020123:Sirolimus
references.citation: Ann N Y Acad Sci. 2006 Apr;1068:447-57
references.pmid: 16831942
references.citation: J Cell Biochem. 2010 May 15;110(2):438-46
references.pmid: 20225273
references.citation: Curr Opin Support Palliat Care. 2008 Sep;2(3):204-10
references.pmid: 18685422
references.citation: Curr Opin Oncol. 2009 Jul;21(4):338-44
references.pmid: 19444102
references.citation: Clin Orthop Relat Res. 2004 Sep;(426):103-9
references.pmid: 15346059
references.citation: Cancer Res. 2005 Mar 15;65(6):2406-11
references.pmid: 15781656
references.citation: J Bone Miner Res. 2000 Apr;15(4):640-9
references.pmid: 10780856
references.citation: Am J Pathol. 2000 Mar;156(3):761-7
references.pmid: 10702390
references.citation: Bone. 2001 Apr;28(4):370-7
references.pmid: 11336917
references.citation: J Mol Med (Berl). 2010 Mar;88(3):227-33
references.pmid: 19943027
references.citation: Oncogene. 2006 Oct 16;25(48):6347-60
references.pmid: 17041621
references.citation: Am J Pathol. 2005 Jul;167(1):117-28
references.pmid: 15972958
references.citation: Mol Endocrinol. 2008 Jan;22(1):176-85
references.pmid: 17885208
references.citation: Blood. 2005 Sep 1;106(5):1801-7
references.pmid: 15886325
references.citation: Genes Dev. 2010 Jan 1;24(1):15-20
references.pmid: 20047998
references.citation: Bioessays. 2010 Oct;32(10):885-93
references.pmid: 20726009
references.citation: Genes Dev. 2000 Aug 1;14(15):1920-32
references.pmid: 10921906
references.citation: BMC Cancer. 2010 Aug 29;10:462
references.pmid: 20799989
references.citation: Am J Clin Pathol. 2002 Feb;117(2):210-6
references.pmid: 11863217
references.citation: Lancet Oncol. 2010 Mar;11(3):275-80
references.pmid: 20149736
references.citation: Annu Rev Pathol. 2008;3:457-84
references.pmid: 18039135
references.citation: J Clin Oncol. 2005 Aug 10;23(23):5314-22
references.pmid: 15955899
references.citation: EMBO J. 2009 Jun 17;28(12):1769-81
references.pmid: 19440205
references.citation: Int Orthop. 2006 Dec;30(6):484-9
references.pmid: 17013643
references.citation: Blood. 2007 Apr 15;109(8):3253-9
references.pmid: 17158225